
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically O... Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.48 | -7.13224368499 | 6.73 | 7.08 | 6.2322 | 39458 | 6.66796209 | CS |
4 | -0.9 | -12.5874125874 | 7.15 | 8.24 | 6.2322 | 99524 | 7.24927087 | CS |
12 | 1.75 | 38.8888888889 | 4.5 | 10.5 | 3.7223 | 172778 | 7.29943206 | CS |
26 | 2.38 | 61.4987080103 | 3.87 | 10.5 | 3.7223 | 93870 | 6.98728977 | CS |
52 | 3.72 | 147.035573123 | 2.53 | 10.5 | 2.22 | 69239 | 6.31260908 | CS |
156 | 2.83 | 82.7485380117 | 3.42 | 10.5 | 1.53 | 37429 | 5.49534312 | CS |
260 | 0.77 | 14.0510948905 | 5.48 | 12.32 | 1.53 | 343976 | 9.05887761 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約